Is Coral Laboratories Ltd (524506) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Coral Laboratories Ltd is a average quality company .

Is Coral Laboratories Ltd (524506) undervalued or overvalued?

The key valuation ratios of Coral Laboratories Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Coral Laboratories Ltd (524506) share price return in the past 10 years?

Coral Laboratories Ltd share price has appreciated 0.3% annually (CAGR) over the past ten years.

Is Coral Laboratories Ltd (524506) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Coral Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Coral Laboratories Ltd (524506)?

Company share prices are keep on changing according to the market conditions. The current trading price of Coral Laboratories Ltd (524506) on 07-May-2026 12:51:00 at 12:51 is 443.70.

What is the market cap of Coral Laboratories Ltd (524506)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 07-May-2026 at 12:51, the market cap of Coral Laboratories stood at Rs. 150.12 Cr.

What is the P/E ratio of Coral Laboratories?

The latest standalone P/E ratio of Coral Laboratories as of 07-May-2026 is 10.73.

What is the P/B ratio of Coral Laboratories Ltd (524506)?

The latest standalone P/B ratio of Coral Laboratories Ltd (524506) as of 07-May-2026 is 0.70.

What is the 52-week high and low of Coral Laboratories Ltd (524506)?

The 52-week high of Coral Laboratories Ltd (524506) is Rs. 784.55 and the 52-week low is Rs. 360.00.

What is the TTM revenue of Coral Laboratories Ltd (524506)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Coral Laboratories is Rs. 87.56 (Cr.).

Coral Laboratories Ltd (524506) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Coral Laboratories Ltd (524506)
Brand: Coral Laboratories

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	26.9%	27.2%	15.9%	13.4%	7.9%	13.4%	7.9%	5.4%	12.5%	17%	-
Value Creation Index ⓘ	0.9	1.0	0.1	0.0	-0.4	-0.1	-0.4	-0.6	-0.1	0.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	77	95.5	92.5	91.1	70.6	96.6	75.6	78.1	83.7	115	88
Sales YoY Gr.	-	24%	-3.1%	-1.5%	-22.5%	36.8%	-21.7%	3.3%	7.1%	37.5%	-
Adj EPS ⓘ	32.9	46.2	32.6	25.4	16.6	37.9	22.6	11.6	42.7	66.2	39.2
YoY Gr.	-	40.5%	-29.3%	-22.1%	-34.8%	128.6%	-40.4%	-48.6%	266.7%	55.2%	-
BVPS (₹) ⓘ	196.4	305.5	325.6	318.5	323.8	382.5	436.8	433.3	496.8	563.2	604.2
Adj Net Profit ⓘ	11.7	16.5	11.7	9.1	5.9	13.6	8.1	4.2	15.2	23.7	14
Cash Flow from Ops. ⓘ	5.1	10.8	13.5	-0.9	-3.9	0.9	6.1	12.7	-5.5	-1.2	-
Debt/CF from Ops. ⓘ	0.1	0.2	0.1	-1.6	-1.5	6.7	1	0	0	-2.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	4.6%	10.3%	15%	37.5%
Adj EPS ⓘ	8.1%	31.9%	43.1%	55.2%
BVPSⓘ	12.4%	11.7%	8.8%	13.4%
Share Price	0.3%	1.4%	18.8%	-32.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	18.2	18.4	10.3	7.9	5.2	10.7	5.5	2.7	9.2	12.5	6.7
Op. Profit Mgn % ⓘ	21.4	24.4	16.6	13.6	7.7	16.4	10.9	4.9	19.4	22.8	13.4
Net Profit Mgn % ⓘ	15.2	17.3	12.6	10	8.4	14	10.7	5.3	18.2	20.6	16
Debt to Equity ⓘ	0	0	0	0	0.1	0.1	0	0	0	0	-
Working Cap Days ⓘ	241	229	243	247	332	273	382	346	301	226	335
Cash Conv. Cycle ⓘ	127	127	140	129	181	146	213	180	120	92	296

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 15.01%

Net Profit is growing at healthy rate in last 3 years 43.07%

Return on Equity has declined versus last 3 years average to 6.70%

Sales growth is not so good in last 4 quarters at -22.58%

	Standalone	Consolidated
TTM EPS (₹)	39.2	-
TTM Sales (₹ Cr.)	87.6	-
BVPS (₹) ⓘ	604.2	-
Reserves (₹ Cr.) ⓘ	212	-
P/BV ⓘ	0.70	-
PE ⓘ	10.73	-

From the Market
52 Week Low / High (₹)	360.00 / 784.55
All Time Low / High (₹)	7.25 / 1190.00
Market Cap (₹ Cr.)	150
Equity (₹ Cr.)	3.6
Face Value (₹)	10
Industry PE ⓘ	44.8

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	77	95	92	91	71	97	76	78	84	115
Operating Expenses ⓘ +	61	72	77	79	65	81	67	74	67	89
Manufacturing Costs	22	32	25	28	19	26	21	22	23	25
Material Costs	27	29	36	32	27	32	26	31	22	35
Employee Cost	5	7	9	10	10	10	11	11	11	15
Other Costs ⓘ	7	5	8	9	9	13	10	10	12	14
Operating Profit ⓘ	16	23	15	12	5	16	8	4	16	26
Operating Profit Margin (%)	21.4%	24.4%	16.6%	13.6%	7.7%	16.4%	10.9%	4.9%	19.4%	22.8%
Other Income ⓘ +	3	3	4	5	6	4	5	7	7	9
Exceptional Items ⓘ	0	-0	0	0	0	0	1	0	-0	-1
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	2	2	2	2	2	2	2	2	2	2
Profit Before Tax ⓘ	17	25	18	16	9	18	12	8	21	32
Tax ⓘ	5	8	6	5	2	4	3	2	5	8
Profit After Tax	12	16	12	10	7	14	9	6	16	24
PAT Margin (%)	16.1%	17.1%	13.5%	11.2%	10.1%	14.0%	12.0%	8.3%	18.9%	21.0%
Adjusted EPS (₹)	34.7	45.6	34.8	28.6	20.0	37.9	25.3	18.0	44.2	67.6
Dividend Payout Ratio (%)	8.70%	11%	5.70%	7%	0%	0%	0%	0%	4.50%	2.20%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	70	109	116	114	116	137	156	155	177	201
Share Capital ⓘ	4	4	4	4	4	4	4	4	4	4
Reserves ⓘ	67	106	113	110	112	133	152	151	174	198
Debt +	0	2	2	1	6	6	6	0	0	4
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	2	2	1	6	6	6	0	0	4
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	10	10	13	13	14	15	9	4	13	7
Others Liabilities ⓘ	9	10	9	8	9	10	19	15	15	18
Total Liabilities ⓘ	89	131	140	136	144	168	190	174	206	229
Fixed Assets
Net Fixed Assets ⓘ +	18	18	21	22	22	20	23	24	23	22
Gross Block	34	32	37	39	40	41	46	49	50	51
Accumulated Depreciation	16	14	15	17	19	21	23	25	27	29
CWIP ⓘ	0	0	0	0	0	1	2	0	0	2
Investments ⓘ	5	39	46	29	26	33	46	41	50	52
Inventories	13	21	18	16	19	22	18	13	15	10
Trade Receivables	28	31	32	30	34	39	38	23	28	34
Cash Equivalents ⓘ	9	12	11	23	30	35	37	40	61	80
Others Assets ⓘ	17	10	12	15	13	18	25	32	28	29
Total Assets ⓘ	89	131	140	136	144	168	190	174	206	229

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	5	11	13	-1	-4	1	6	13	-5	-1
PBT ⓘ	17	25	18	16	9	18	11	8	21	33
Adjustment ⓘ	0	0	1	1	1	-0	-0	0	-2	-3
Changes in Working Capital ⓘ	-6	-5	0	-13	-13	-13	-0	6	-20	-24
Tax Paid ⓘ	-5	-9	-6	-5	-1	-3	-4	-2	-5	-7
Cash Flow From Investing Activity ⓘ +	-3	-10	-13	3	-2	-0	-6	-3	1	-0
Capex	-1	-2	-5	-3	-1	-1	-6	-2	-1	-0
Net Investments	-3	-9	-9	5	0	0	-2	-2	0	-0
Others ⓘ	2	1	1	1	-0	1	2	1	2	1
Cash Flow From Financing Activity ⓘ +	-0	0	-3	-1	4	0	0	-6	0	3
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	-0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Dividend Paid ⓘ	0	-1	-2	-1	-1	0	0	0	0	-1
Others ⓘ	0	2	0	-0	4	0	0	-6	0	4
Net Cash Flow ⓘ	2	1	-2	1	-2	1	0	4	-4	1

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	19.18	18.17	11.04	8.88	6.22	10.74	6.18	4.15	9.5	12.76
ROCE (%)	26.93	27.23	15.91	13.44	7.86	13.35	7.87	5.41	12.48	17.04
Asset Turnover Ratio	0.97	0.87	0.68	0.66	0.5	0.62	0.42	0.43	0.44	0.53
PAT to CFO Conversion(x)	0.42	0.69	1.08	-0.1	-0.57	0.07	0.67	2.17	-0.31	-0.04
Working Capital Days
Receivable Days	122.10	111.70	122.90	124.10	167.40	139	186.50	143.80	112.60	98.10
Inventory Days	55.20	65	75.60	67.60	91.70	77.40	96.60	72.10	60.30	39.70
Payable Days	106.80	126	116.40	144.30	181.20	164.80	167.30	75.80	146.80	102.30

About Coral Laboratories Ltd

Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.

The Company with deep basket of products is focused in hostlic human welfare and is bringing planfort to people with its Inflammatory, Bacterial, Biotic, Protein deficiencies & Skin conditions. Medicines across the nation, manufactured under the ZEST group & MOXBRO group being the most popular brands across the nation, manufactured by the company.Coral Laboratories has been following a steady growth path on the pillars of its philosophy of â€œTotal Quality Managementâ€ & â€œQuality Products at Affordable Pricesâ€.

The state-of-the art manufacturing facilities meet the stringent and over changing quality requirement of the most discerning buyers. Coral has a multi location manufacturing facilities based on Baroda, Daman & Vasai for strategies convenience. The facilities carrying WHO-GMP & ISO 9001 : 2000 certification. The new manufacturing facilities under expansion to have UK â€“ MHRA and USâ€“ FDA certification.

Coral has one of the best quality control laboratory in indian pharmaceuticals industry equipped with latest and sensitive laboratory instruments.

Product range of the company includes:

Capsules & Dry Syrups
Tablets
Liquid Orals
Kits
Ointment & Cream
Injection â€“ Eye â€“ Ear Drops
Others

Achievements/ recognition:

WHO GMP certification issued by the Food & Drugs Control Administration
ISO 9001-2000 Quality certification issued by American Quality Assessors.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Coral Laboratories Ltd (524506) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Coral Laboratories Share Price